Adtalem Global Education (NYSE:CVSA) Shares Up 13.6% Following Earnings Beat

Shares of Adtalem Global Education Inc. (NYSE:CVSA) were up 13.6% on Friday following a stronger than expected earnings report. The stock traded as high as $141.91 and last traded at $141.1350. Approximately 498,019 shares traded hands during mid-day trading, an increase of 34% from the average session volume of 370,475 shares. The stock had previously closed at $124.26.

The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. The company had revenue of $501.38 million for the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS.

Analyst Upgrades and Downgrades

CVSA has been the topic of a number of research reports. Barrington Research reissued an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a report on Monday, June 8th. Wall Street Zen cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Finally, Truist Financial lifted their price target on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $155.00.

Insiders Place Their Bets

In related news, SVP Douglas G. Beck sold 2,650 shares of the stock in a transaction that occurred on Tuesday, July 7th. The stock was sold at an average price of $135.40, for a total transaction of $358,810.00. Following the completion of the transaction, the senior vice president directly owned 35,509 shares of the company’s stock, valued at approximately $4,807,918.60. This represents a 6.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert J. Phelan sold 2,900 shares of the firm’s stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $135.41, for a total value of $392,689.00. Following the transaction, the chief financial officer owned 52,906 shares of the company’s stock, valued at $7,164,001.46. This represents a 5.20% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 15,694 shares of company stock worth $2,098,614 over the last three months. 2.50% of the stock is currently owned by company insiders.

Adtalem Global Education Stock Up 13.5%

The firm’s fifty day simple moving average is $124.22. The firm has a market capitalization of $4.80 billion, a PE ratio of 21.89, a PEG ratio of 0.97 and a beta of 0.62. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.